Literature DB >> 6286853

Cloning of DNA fragments from the left end of the adenovirus type 12 genome: transformation by cloned early region 1.

P J Byrd, W Chia, P W Rigby, P H Gallimore.   

Abstract

The human adenovirus serotype 12 (Ad-12) EcoRI-C DNA fragment (0 to 16.5 map units) was cloned in the plasmid vector pAT153. This cloned Ad-12 EcoRI-C DNA fragment was subcloned generating recombinant plasmids which contained the Ad-12 SalI-C fragment (0 to 10.3 map units), the Ad-12 HindIII-G fragment (0 to 6 X 8 map units) and the Ad-12 AccI-H fragment (0 to 4 X 7 map units). Thus, we constructed recombinant plasmids which contain Ad-12 DNA sequences which represent all or part of the virus transforming gene region. The capacity of the cloned Ad-12 EcoRI-C DNA fragment to transform rat cells in vitro was assessed using the focus assay on primary cultures of rat cells. The specific transforming activity of this recombinant plasmid was in the same range as that found for intact Ad-12 DNA. Transformed foci which were induced by the cloned Ad-12 EcoRI-C DNA fragment were established as cell lines and the presence of Ad-12 DNA in these lines was demonstrated using the Southern blotting technique.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286853     DOI: 10.1099/0022-1317-60-2-279

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats.

Authors:  C Edbauer; C Lamberti; J Tong; J Williams
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture.

Authors:  P H Gallimore; P S Lecane; S Roberts; S M Rookes; R J Grand; J Parkhill
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Host gene expression modulated by Zika virus infection of human-293 cells.

Authors:  Sachi Horibata; Tadahisa Teramoto; Navin Vijayarangan; Skyler Kuhn; Raji Padmanabhan; Sona Vasudevan; Michael Gottesman; Radhakrishnan Padmanabhan
Journal:  Virology       Date:  2020-10-06       Impact factor: 3.616

4.  Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 E1 gene.

Authors:  K Shiroki; S Hashimoto; I Saito; Y Fukui; Y Fukui; H Kato; H Shimojo
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

5.  Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines.

Authors:  J L Whittaker; P J Byrd; R J Grand; P H Gallimore
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

6.  Adenovirus type 12-transformed rat embryo brain and rat liver epithelial cell lines: adenovirus type 12 genome content and viral protein expression.

Authors:  C Paraskeva; K W Brown; A R Dunn; P H Gallimore
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

7.  Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12.

Authors:  G C Telling; J Williams
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.

Authors:  S Soddu; A M Lewis
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Replication of origin containing adenovirus DNA fragments that do not carry the terminal protein.

Authors:  B G van Bergen; P A van der Ley; W van Driel; A D van Mansfeld; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1983-04-11       Impact factor: 16.971

10.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.